FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas

Mark J. Smyth, Gavin P. Dunn, Robert D. Schreiber, Cancer Immunosurveillance and Immunoediting: The Roles of Immunity in Suppressing Tumor Development and Shaping Tumor Immunogenicity Advances in Immunology. ,vol. 90, pp. 1- 50 ,(2006) , 10.1016/S0065-2776(06)90001-7

David N. Louis, WHO classification of tumours of the central nervous system International Agency for Research on Cancer. ,(2007)

F. S. Regateiro, S. P. Cobbold, H. Waldmann, CD73 and adenosine generation in the creation of regulatory microenvironments. Clinical and Experimental Immunology. ,vol. 171, pp. 1- 7 ,(2013) , 10.1111/J.1365-2249.2012.04623.X

Camie W. Y. Chan, Lyndsey S. Kay, Rachel G. Khadaroo, Matthew W. C. Chan, Sophia Lakatoo, Kevin J. Young, Li Zhang, Reginald M. Gorczynski, Mark Cattral, Ori Rotstein, Gary A. Levy, Soluble Fibrinogen-Like Protein 2/Fibroleukin Exhibits Immunosuppressive Properties: Suppressing T Cell Proliferation and Inhibiting Maturation of Bone Marrow-Derived Dendritic Cells Journal of Immunology. ,vol. 170, pp. 4036- 4044 ,(2003) , 10.4049/JIMMUNOL.170.8.4036

Itay Shalev, Hao Liu, Cheryl Koscik, Agata Bartczak, Mojib Javadi, Kit Man Wong, Asif Maknojia, Wei He, Ming Feng Liu, Jun Diao, Erin Winter, Justin Manuel, Doug McCarthy, Mark Cattral, Jennifer Gommerman, David A. Clark, M. James Phillips, Reginald R. Gorczynski, Li Zhang, Greg Downey, David Grant, Myron I. Cybulsky, Gary Levy, Targeted Deletion of fgl2 Leads to Impaired Regulatory T Cell Activity and Development of Autoimmune Glomerulonephritis Journal of Immunology. ,vol. 180, pp. 249- 260 ,(2008) , 10.4049/JIMMUNOL.180.1.249

Marc A. Gavin, Jeffrey P. Rasmussen, Jason D. Fontenot, Valeria Vasta, Vincent C. Manganiello, Joseph A. Beavo, Alexander Y. Rudensky, Foxp3-dependent programme of regulatory T-cell differentiation Nature. ,vol. 445, pp. 771- 775 ,(2007) , 10.1038/NATURE05543

Sivashankary Yuwaraj, JinWen Ding, Mingfeng Liu, Philip A. Marsden, Gary A. Levy, Genomic characterization, localization, and functional expression of FGL2, the human gene encoding fibroleukin: a novel human procoagulant. Genomics. ,vol. 71, pp. 330- 338 ,(2001) , 10.1006/GENO.2000.6444

Abhisek Mitra, Lopa Mishra, Shulin Li, Technologies for deriving primary tumor cells for use in personalized cancer therapy. Trends in Biotechnology. ,vol. 31, pp. 347- 354 ,(2013) , 10.1016/J.TIBTECH.2013.03.006

Wentao Jia, Colleen Jackson-Cook, Martin R. Graf, Tumor-infiltrating, myeloid-derived suppressor cells inhibit T cell activity by nitric oxide production in an intracranial rat glioma+vaccination model Journal of Neuroimmunology. ,vol. 223, pp. 20- 30 ,(2010) , 10.1016/J.JNEUROIM.2010.03.011

Katharina Foerster, Ahmed Helmy, Yi Zhu, Ramzi Khattar, Oyedele A. Adeyi, Kit Man Wong, Itay Shalev, David A. Clark, Pui-Yuen Wong, Elizabeth J. Heathcote, Melville J. Phillips, David R. Grant, Eberhard L. Renner, Gary A. Levy, Nazia Selzner, The novel immunoregulatory molecule FGL2: A potential biomarker for severity of chronic hepatitis C virus infection Journal of Hepatology. ,vol. 53, pp. 608- 615 ,(2010) , 10.1016/J.JHEP.2010.04.020